| (a) A youth facility (facility) shall stock at least
one unassigned pediatric epinephrine auto-injector pack (two doses)
and one adult epinephrine auto-injector pack (two doses). The number
of additional pediatric and adult packs may be determined by a facility
assessment led by an authorized health-care provider, based on available
resources, in accordance with this subchapter.
(b) A facility with greater than 100 youth and staff
that voluntarily adopts an unassigned epinephrine auto-injector policy
shall conduct an assessment to determine the minimum number of additional
unassigned epinephrine auto-injectors and may consider as a part of
an assessment:
(1) consultation with administrators, office of risk
management, food services management, or any department involved with
public well-being;
(2) facility geography, including high risk areas where
food exposure or environmental trigger exposure may occur;
(3) enrollment limit and number of personnel; and
(4) the number of youth with an identified allergy.
(c) An unassigned epinephrine auto-injector policy
shall include:
(1) a designated administrator to coordinate and manage
policy implementation;
(2) an assessment, if greater than 100 youth and staff;
(3) a training policy for personnel that is consistent
with §40.22 of this subchapter (relating to Training);
(4) a requirement to obtain a prescription from an
authorized healthcare provider each year to stock, possess, and maintain
the minimum number of unassigned epinephrine auto-injectors, described
in §40.20 of this subchapter (relating to Applicability), to
be dispensed by an authorized pharmacy, as defined by Texas Occupations
Code, Chapter 560, §560.001;
(5) a requirement to obtain a standing order designating
how and when to administer an unassigned epinephrine auto-injector;
(6) the number of unassigned epinephrine auto-injectors
at the facility;
(7) a process to verify the inventory of unassigned
epinephrine auto-injectors at regular intervals for expiration and
replacement;
(8) a plan to replace, as soon as reasonably possible,
any unassigned epinephrine auto-injector when used or close to expiration;
(9) a requirement that the unassigned epinephrine auto-injectors
be stored according to manufacturer's instructions;
(10) designation of one or more secure and easily-accessible
locations to store unassigned epinephrine auto-injectors; and
(11) procedures for notifying local emergency medical
services when a person is suspected of experiencing anaphylaxis and
when an epinephrine auto-injector is administered.
(d) If a facility implements an unassigned epinephrine
auto-injector policy under this subchapter, the facility must provide
written or electronic notice to a parent or guardian of each youth
enrolled within 15 calendar days.
(e) If a facility changes or discontinues the policy
adopted under this subchapter, the facility must provide a written
or electronic notice detailing the change or discontinuation to a
parent or guardian of each youth within 15 calendar days of the change
or discontinuation.
|
